Date of Graduation


Document Type



allogenic, stem cell transplants, survivorship care plans, common complications

Degree Name

Doctor of Nursing Practice (DNP)

Degree Level



Michele Kilmer

Committee Member

Angela Stewart

Second Committee Member

Mary Alverson

Third Committee Member

Amy Hiegel


Stem cell transplants (SCTs) are complicated treatments utilized to treat hematologic malignancies and other disorders, such as multiple myeloma, non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, acute myeloid leukemia, neuroblastomas, germ cell tumors, amyloidosis, and autoimmune disorders such as systemic lupus erythematosus and systemic sclerosis. The complex care of patients undergoing SCTs place them at high risk for adverse outcomes, including infection, cytomegalovirus, graft vs host disease, secondary new cancers, infertility, and sexual dysfunction (American Cancer Society, 2020). Survivorship care plans (SCPs) are a vital part of the discharge process to educate allogenic SCT patients about post-transplantation care. SCPs are implemented to reduce the risk of common complications and hospital re-admissions in post-SCT patients. The purpose of this project is to use SCPs to reduce 30-day re-admission rates of allogenic SCT patients. A review of literature was conducted to analyze the impact of SCPs on post-transplantation knowledge of preventative measures and common complications. The SCP Questionnaire was created to measure knowledge received from the SCP to highlight the effectiveness of preventative measures and common complications post-transplantation. Kurt Lewin’s Change Theory provided the underlying theoretical framework for this project’s implementation process. The methodology used was a non-randomized quasi-experiment with purposive sampling of allogenic patients that included a retrospective chart review measuring 30-day readmissions, demographics, and the number of patients discharged post-transplant. The Wilcoxon Signed Ranked Test was utilized to demonstrate statistical significance in 30-day readmission rates through post-transplant knowledge and managed care.